People taking semaglutide medicines such as Wegovy or Ozempic alongside the anticoagulant warfarin may need more frequent blood tests, according to a pharmacist, although the combination is not considered inherently unsafe.
Charlotte Parker-Lennox, prescribing pharmacist at LloydsPharmacy Online Doctor, said caution may be needed in some cases when it comes to other medications, but there is no cause for alarm.
What the pharmacist said
Semaglutide is used to treat obesity (Wegovy) or manage type 2 diabetes (Ozempic) and is only available with a prescription, either through the NHS or privately. Ozempic is not licensed as a weight loss treatment.
The NHS website notes that some medicines, herbal remedies, and supplements may not mix well with semaglutide. This includes warfarin, an anticoagulant sometimes called a blood thinner, used to treat and prevent blood clots, including deep vein thrombosis and pulmonary embolism.
Parker-Lennox told the Mirror: “While warfarin and semaglutide are not inherently an unsafe combination, in practice there is caution around their being prescribed together. One reason is that semaglutide slows how quickly food leaves the stomach, which can affect how quickly medicines move through the digestive system.”
She added: “There is no major direct pharmacological interaction between the two medications, but patients taking both should have their blood tested for how quickly it clots – known as an International Normalised Ratio or INR – particularly when starting semaglutide or following a dose increase.”
Monitoring and symptoms
Parker-Lennox, who studied at King’s College London and previously worked supporting NHS 111 providing clinical advice, triage and medication management, said: “Patients should inform their anticoagulation or warfarin clinic if they are taking semaglutide so that any INR changes can quickly be identified. Factors such as weight loss, reduced food intake, nausea, vomiting or changes in dietary intake of vitamin K, which aids clotting, can all influence INR levels.”
She reassured that if patients' INR is “monitored proactively, the risks associated with using warfarin and semaglutide together are generally low.” However, warfarin needs careful, closely monitored dosing to remain safe and effective.
Patients should be alert for signs their blood may be too thin and seek medical advice if they notice unusual bruising or bleeding, frequent or prolonged nosebleeds, black or tarry stools, or blood in the urine.
Parker-Lennox urged people to follow their doctor’s advice on INR tests and warfarin dose. She concluded: “Patients should always follow the advice of their prescribing clinician and anticoagulation service regarding INR testing and warfarin dose adjustments.”
The NHS also reminds patients: “Before you use semaglutide, tell your doctor or a pharmacist if you're taking any other medicines, herbal remedies, vitamins or supplements.”